BioAge Labs, Inc. (BIOA)
NASDAQ: BIOA · Real-Time Price · USD
18.49
+1.50 (8.83%)
Apr 17, 2026, 4:00 PM EDT - Market closed
BioAge Labs Stock Forecast
Stock Price Forecast
The 6 analysts that cover BioAge Labs stock have a consensus rating of "Strong Buy" and an average price target of $51.5, which forecasts a 178.53% increase in the stock price over the next year. The lowest target is $12 and the highest is $73.
Price Target: $51.5 (+178.53%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for BioAge Labs stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 2 | 3 | 3 |
| Buy | 0 | 0 | 1 | 2 | 2 | 2 |
| Hold | 2 | 3 | 2 | 2 | 1 | 1 |
| Sell | 1 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Strong Buy Initiates $50 | Strong Buy | Initiates | $50 | +170.42% | Mar 27, 2026 |
| Citigroup | Citigroup | Strong Buy Maintains $15 → $52 | Strong Buy | Maintains | $15 → $52 | +181.23% | Mar 10, 2026 |
| Oppenheimer | Oppenheimer | Buy Initiates $60 | Buy | Initiates | $60 | +224.50% | Feb 25, 2026 |
| Jefferies | Jefferies | Hold → Strong Buy Upgrades $9 → $62 | Hold → Strong Buy | Upgrades | $9 → $62 | +235.32% | Feb 18, 2026 |
| Piper Sandler | Piper Sandler | Buy Initiates $73 | Buy | Initiates | $73 | +294.81% | Jan 27, 2026 |
Financial Forecast
Revenue This Year
73.84M
from 9.00M
Increased by 720.93%
Revenue Next Year
2.82M
from 73.84M
Decreased by -96.18%
EPS This Year
-2.65
from -2.24
EPS Next Year
-2.67
from -2.65
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 498.8M | 10.5M | |||
| Avg | 73.8M | 2.8M | |||
| Low | n/a | -2.2M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 5,444.7% | -85.8% | |||
| Avg | 720.9% | -96.2% | |||
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -2.39 | -1.74 | |||
| Avg | -2.65 | -2.67 | |||
| Low | -3.07 | -3.63 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.